Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-24

Clinical Trial Update: Lowering Uric Acid in Live Kidney Donors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lowering uric acid in live kidney donors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oslo University Hospital | Conditions: Renal Transplant Donor of Left Kidney, Renal Transplant Donor of Right Kidney | Phase 2 | Status: COMPLETED